TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited ( (AU:PME) ) has shared an update.
Pro Medicus Limited has announced an update regarding its ongoing on-market buy-back program. As of November 14, 2025, the company has repurchased a total of 31,086 ordinary fully paid securities, including 3,904 bought back on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$320.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software solutions for medical professionals. The company focuses on delivering innovative products that enhance medical imaging capabilities, catering to a global market of healthcare providers.
Average Trading Volume: 179,305
Technical Sentiment Signal: Buy
Current Market Cap: A$26.88B
Learn more about PME stock on TipRanks’ Stock Analysis page.